GSK: Leveraging GenAI in Commercial
Content to Improve MLR Review

"The area where GenAI has the most potential is MLR
and it's exciting to see Veeva embrace that with MLR Bot."

- Dr. Samin Saeed, Vice President, Early Assets Medical, GSK

Hear Dr. Samin Saeed at GSK discuss the medical affairs evolution, the explosion of GenAI in the industry and the specific use cases where it can be the most impactful.